A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

NCT00481819 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: FK506MR
DRUG: Prograf
DRUG: Mycophenolate Mofetil
DRUG: Methylprednisolone
DRUG: Prednisolone

Sponsor

Astellas Pharma Inc